French drugmaker Sanofi scored a win Wednesday when a Delaware federal judge invalidated patents related to rival Amgen Inc.’s cholesterol-lowering drug Repatha, upending a February jury verdict that had gone largely in Amgen’s favor…

Read this piece in its entirety at Law360.